login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
LIFECORE BIOMEDICAL INC (LFCR) Stock News
USA
- NASDAQ:LFCR -
US5147661046
-
Common Stock
8.22
USD
+0.48 (+6.2%)
Last: 11/12/2025, 8:00:02 PM
7.77
USD
-0.45 (-5.47%)
Pre-Market:
11/13/2025, 7:18:11 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
LFCR Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical to Participate in Upcoming Investor Conferences
7 days ago - By: Zacks Investment Research
- Mentions:
BFRI
Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates
7 days ago - By: Benzinga
- Mentions:
STVN
PODD
AMRK
SOLV
...
Earnings Scheduled For November 6, 2025
9 days ago - By: Zacks Investment Research
- Mentions:
HRMY
Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Miss Estimates
14 days ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025
15 days ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company
3 months ago - By: The Motley Fool
Lifecore (LFCR) Q4 Revenue Beats 3%
3 months ago - By: Benzinga
- Mentions:
GSAT
PGY
ADV
REAL
...
Earnings Scheduled For August 7, 2025
16 days ago - By: Lifecore Biomedical, Inc.; PolyPeptide Laboratories, Inc.
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
a month ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
2 months ago - By: Bragar Eagel & Squire
LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
2 months ago - By: Lifecore Biomedical, Inc.
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
2 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical to Participate in Upcoming Investor Conferences
3 months ago - By: Yahoo Finance
Does LifeCore (LFCR) Have a High Expected Value?
3 months ago - By: Bragar Eagel & Squire
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
3 months ago - By: Zacks Investment Research
- Mentions:
GRAL
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates
3 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
3 months ago - By: Zacks Investment Research
- Mentions:
IBRX
ImmunityBio (IBRX) Reports Q2 Loss, Tops Revenue Estimates
3 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025
4 months ago - By: Lifecore Biomedical, Inc.
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
5 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
6 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
6 months ago - By: Yahoo Finance
- Mentions:
AMZN
What Makes Lifecore Biomedical (LFCR) a Beneficiary of the Trade Policies?
6 months ago - By: Yahoo Finance
- Mentions:
UNH
HD
AZO
HSBC
...
UnitedHealth downgraded, Home Depot upgraded: Wall Street's top analyst calls
7 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
7 months ago - By: Lifecore Biomedical, Inc.
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
7 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
7 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
8 months ago - By: Zacks Investment Research
- Mentions:
DARE
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates
8 months ago - By: Lifecore Biomedical, Inc.
Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025
8 months ago - By: Lifecore Biomedical, Inc.
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
Please enable JavaScript to continue using this application.